The Chronic Pain Market is anticipated to grow from US$ 73.14 Billion in 2023 to US$ 142.53 Billion by 2033, rising at a CAGR of 6.9% during the forecast period. Globally, there were more than 187 Million cases of chronic pain in 2020, and from 2023 to 2033, it is predicted that this number would increase dramatical.
The Shanti Therapeutics Focus on Chronic Pain Market with Psychedelics
Vancouver, British Columbia (Newsfile Corp. - February 10, 2022) - Global Wellness Strategies Inc. (CSE: GWS) (FSE: O3X4) (OTCQB:
The Shanti Therapeutics Focus on Chronic Pain Market with PsychedelicsGlobal Wellness Strategies Inc. changes symbol to GWS and introduces Dr. Sud Agarwal BSc, MB ChB, FANZCA, the Chairman of Cannvalate Pty Ltd. and Shanti Therapeutics. His experience and expertise in the psychedelic industry will contribute significantly to our efforts in the space moving forward.GWS Symbol Change:Global Wellness Strategies .
Global Wellness Signs Definitive Agreement with Cannvalate Australia investingnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investingnews.com Daily Mail and Mail on Sunday newspapers.